USE OF LAUREQUINONE AS AN ANTIPARASITIC AGENT

Patent number:

P202030582

No items found.

The invention discloses the use of the compound Laurequinone, in particular as a drug for human or veterinary use, and more particularly in the field of parasitic diseases. Furthermore, the present invention relates to methods for obtaining said compound. Laurequinone presented good activity against promastigotes of Leishmania amazonensis, showing low mean inhibitory concentration (CI50) and low mean cytotoxic concentration (CC50) values.

Countries:

Spain

Regions:

Canary Islands

Centers:

UNIVERSIDAD DE LA LAGUNA

Other entities:

Universidad Autónoma de Nuevo León (UANL)

Sectors:

Health

Subsectors:

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

SDG03: Good health and well-being

Applications

Use in the treatment of Leishmaniasis. Better selectivity than other conventional treatments such as Miltefosine.

Comments

Other related patents

Health

IN VITRO METHOD FOR DETECTING TUMOR GROWTH AND DIAGNOSING OR PROGNOSTICATING THE RISK OF METASTASIS IN A HUMAN SUBJECT THAT HAS BEEN DIAGNOSED WITH UVEAL MELANOMA

Countries

Spain

Health

Anticancer agents based on cyclopentenones

Countries

Greece

Chemicals

Health

Circular Economy

Other

Electrochemical reactor for obtaining ozone in the gas phase

Countries

Spain

Get back to patents directory